Skip to content
Menu

Real moms, real GLP-1 talk

My Hair on a GLP-1: When It Started, and What Actually Helped

The shedding is on the label at 4% and nobody mentions it. When mine started, the month it peaked, and the two things that made a real difference.

Walked and written by Jenna Marsh — a mom doing this herself, not a treating clinician
On this page

The shower drain, month four

I was not looking for it. I found it the way everyone does — a handful of hair in my fist in the shower, and then the awful few seconds of deciding whether to count it.

For the record: my hair did not fall out. It thinned, noticeably to me and not really to anyone else, and it came back. But month four was genuinely upsetting and nobody had warned me, so here is the version I wish I had read.

It is on the label, with a number

This is not a forum rumour, which was the first thing that helped me.

The Wegovy label lists it, and — unusually — it breaks the numbers down by sex, which almost nobody quotes.

In the adult trials on the 2.4 mg dose, hair loss was reported by 3.3% of patients overall. Split by sex, that is 4% of women against 0.9% of men. On placebo it was 1% overall: 2% of women, and none of the men1.

At the higher 7.2 mg dose the gap widens again — 5.8% overall, but 8.4% of women against 0.2% of men1.

The Zepbound label lists it too, running around 4–5% against 1%2.

So: women, roughly four times the male rate at the standard dose and forty times it at the high one. Small percentages, real effect, heavily concentrated in us, and almost never mentioned in a welcome email.

(If you have seen "4% versus 0%" quoted for Wegovy, that pairing is from the paediatric trial in 12-to-17-year-olds. The adult comparator is not zero.)

One more line from the label worth holding onto: hair loss reactions in treated patients "were associated with weight reduction"1 — the label itself frames this as a consequence of losing weight rather than a direct effect of the drug on hair.

There is proper research now as well. A 2025 retrospective cohort study in the Journal of the American Academy of Dermatology looked specifically at GLP-1 medications and hair loss3, a 2025 systematic review pulled together what is known — noting the signal was first flagged in the FDA's adverse-event reporting system4 — and a scoping review catalogued the dermatologic findings reported with semaglutide5.

So: documented, studied, and still not something anyone tells you at the start.

Why month four, and not month one

The timing is the part that made it make sense.

What dermatologists describe here is the pattern where a physiological stress — rapid weight loss, a big drop in intake, illness, childbirth — pushes a lot of hairs into their resting phase at once. They do not fall out then. They fall out when the next growth cycle pushes them out, which is why the shedding shows up two to four months after the thing that caused it, and why it feels like it comes out of nowhere.

That lag is why I connected it to nothing at first. My dose had been stable for weeks. The cause was the two months before.

It also means the shedding is, by its nature, self-limiting rather than progressive — which is the sentence I most needed at the time.

What actually helped

Protein, properly. Not a shake as an afterthought — actually counting it. When you are not hungry it is very easy to hit a big deficit and eat far too little protein, and hair is one of the first non-essential things a body stops spending on.

Slowing the loss down. The fastest month I had was followed by the worst shedding. I cannot prove that link for you, and I would not pretend the evidence pins rate-of-loss to shedding severity. But it fits the mechanism, and asking my provider to hold my dose rather than climb was the one decision I would repeat.

Getting my iron and ferritin checked rather than assuming. Mine were low-normal, which is worth knowing before you spend money on anything else.

Not panic-buying. I bought two things that did nothing. The evidence for the shedding being self-limiting is better than the evidence for most of what is sold for it.

When it is not this

Worth saying plainly, because "it is just the GLP-1" can hide something else. Patchy loss rather than a general thinning, loss at the front hairline specifically, scalp pain or scaling, or shedding that is still getting worse past six months — those are reasons to see someone rather than wait it out. Thyroid problems and iron deficiency both cause hair loss and both are ordinary, testable things.

The part I did not expect

The hardest bit was not the hair. It was that I felt stupid for minding about it, given everything else that was going well.

You are allowed to mind. It grew back — thinner at the temples than before, if I am honest, and mostly back. And I would still make the same decision.

Frequently asked questions

Is hair loss a real GLP-1 side effect?

Yes, and the Wegovy label breaks it down by sex. On the adult 2.4 mg dose, hair loss was reported by 3.3% of patients overall — 4% of women against 0.9% of men — versus 1% on placebo, which was 2% of women and none of the men. At the 7.2 mg dose it was 5.8% overall, 8.4% of women against 0.2% of men. The Zepbound label lists it at roughly 4-5% against 1%. Note the widely quoted 4% versus 0% pairing is from the paediatric trial, not the adult one. There is also a 2025 retrospective cohort study in the Journal of the American Academy of Dermatology and a 2025 systematic review.

When does the shedding start?

Usually two to four months after the trigger rather than immediately, which is why it feels like it comes from nowhere. A physiological stress such as rapid weight loss pushes many hairs into their resting phase at once, and they are shed when the next growth cycle pushes them out. That lag also means it is self-limiting rather than progressive.

How do you stop hair loss from a GLP-1?

The two things with the best rationale are eating enough protein — easy to under-eat badly when appetite is suppressed — and slowing the rate of weight loss, which means asking about holding a dose rather than climbing. Getting iron and ferritin checked is worth doing before spending money on products, since deficiency causes shedding on its own.

When should I see someone about it?

Patchy loss rather than general thinning, loss at the front hairline specifically, scalp pain or scaling, or shedding still worsening past six months. Thyroid problems and iron deficiency also cause hair loss and are ordinary, testable things — so "it is just the medication" can hide something treatable.

References

  1. U.S. Food and Drug Administration (2025). Wegovy (semaglutide) injection — Prescribing Information (adults, 2.4 mg: hair loss 3.3% overall — 4% female vs 0.9% male — against 1% placebo, 2% female; 7.2 mg: 5.8% overall, 8.4% female; associated with weight reduction; the 4% vs 0% pairing is the paediatric trial). DailyMed / FDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
  2. U.S. Food and Drug Administration (2025). Zepbound (tirzepatide) injection — Prescribing Information (hair loss 4-5% vs 1% placebo). DailyMed / FDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
  3. Burke O, Sa B, Cespedes DA, Sechi A, Tosti A. (2025). Glucagon-like peptide-1 receptor agonist medications and hair loss: A retrospective cohort study. Journal of the American Academy of Dermatology. https://pubmed.ncbi.nlm.nih.gov/39863171/
  4. Alsuwailem OA, Alanazi R, Almutairi HM, et al. (2025). Hair Loss Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Use: A Systematic Review. Cureus. https://pubmed.ncbi.nlm.nih.gov/41111833/
  5. Tran MM, Mirza FN, Lee AC, et al. (2024). Dermatologic findings associated with semaglutide use: A scoping review. Journal of the American Academy of Dermatology. https://pubmed.ncbi.nlm.nih.gov/38554940/

One mom to another, not a doctor: everything here is for learning and figuring out your options, not medical advice, a diagnosis, or a plan for your body. GLP-1 medicines aren't for use in pregnancy or while you're trying to conceive. Before you start, stop, or change anything, talk it through with a clinician who actually knows your history.